| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |